Related Experiment Video

Updated: Jul 20, 2026

Purification and Reconstitution of TRPV1 for Spectroscopic Analysis
11:53

Purification and Reconstitution of TRPV1 for Spectroscopic Analysis

Published on: July 3, 2018

TRAIL-R4-beta: a new splice variant of TRAIL-receptor 4 lacking the cysteine rich domain 1

Andreas Krieg1, Jan Schulte am Esch, Uwe Ramp

  • 1Department of General and Visceral Surgery, Heinrich Heine University Duesseldorf, Germany.

Biochemical and Biophysical Research Communications
|August 29, 2006
PubMed

Insights

Researchers discovered a new splice variant of the TRAIL-R4 decoy receptor, named TRAIL-R4-beta, which has a truncated death domain. This finding suggests alternative splicing fine-tunes programmed cell death regulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Alternative splicing regulates programmed cell death.
  • Splice variants of TNF-related apoptosis inducing ligand (TRAIL) and TRAIL-R2 have been identified.
  • Decoy receptors play a role in modulating apoptosis signaling.

Purpose of the Study:

  • To identify and characterize novel alternative splice variants of TRAIL decoy receptors.
  • To investigate the structural and potential functional implications of these variants.
  • To explore the role of alternative splicing in the fine-tuning of TRAIL-induced apoptosis.

Main Methods:

  • Bioinformatic analysis including BLAST search for gene identification.
  • Analysis of genomic organization of the TRAIL-R4 gene.
  • Characterization of alternative splice variants based on exon structure.

Main Results:

  • Identification of a novel alternative splice variant of the TRAIL-R4 decoy receptor, designated TRAIL-R4-beta.
  • TRAIL-R4-beta variant lacks exon 3, resulting in a truncated death domain.
  • The genomic organization of the TRAIL-R4 gene comprises 9 exons.
  • Loss of exon 3 truncates the first cysteine-rich domain, crucial for ligand-receptor complex formation.

Conclusions:

  • Alternative splicing generates novel TRAIL-R4 variants with altered structural domains.
  • The identified TRAIL-R4-beta variant may influence the TRAIL signaling pathway.
  • Alternative splicing is implicated in the functional fine-tuning of TRAIL-induced programmed cell death.

More Related Videos

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Spare Receptors01:30

Spare Receptors

Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...